Validate: Trustworthy AI to Improve Acute Stroke Outcomes

Launched by HOSPITAL UNIVERSITARI VALL D'HEBRON RESEARCH INSTITUTE · Nov 14, 2022

Keywords

ClinConnect Summary

The "Validate" trial is studying how artificial intelligence (AI) can help doctors predict the outcomes for patients who have suffered an acute ischemic stroke, which is a type of stroke caused by a blockage in the blood flow to the brain. The goal is to create a tool that can quickly analyze patient data and give a better idea of how well a patient might recover from the stroke. This information could help doctors make more informed decisions about treatments. If you or a loved one is 18 years or older and has been diagnosed with an acute ischemic stroke, you may be eligible to participate in this study, as long as there are no signs of bleeding in the brain and you can be reached for follow-up after 90 days.

During the trial, you will receive standard treatment for your stroke from the doctors. A researcher will gather important health information from you using a hospital app and your medical records, but they will not interact with your treatment team. After three months, the researchers will compare the AI predictions about your recovery with your actual health outcomes to see how accurate the tool is. This study is important because it aims to improve how doctors predict stroke recovery, potentially leading to better care for patients in the future.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Subject is 18 years of age or older, or of legal age to give informed consent per state or national law
• • Informed consent for the use of data, obtained from patient or his or her legally designated representative (if locally required)
• Exclusion Criteria:
• • Neuroimaging (CT/MRI) with signs of acute intracranial haemorrhage
• • Serious, advanced, or terminal illness with anticipated life expectancy of less than 3 months
• • Unlikely to be available for 90-day follow-up (e.g., no fixed home address, no telephone, etc.)